Comerica Incorporated issued and sold 16,000,000 depositary shares, each representing a 1/40th interest in a share of its 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. The Series B carries a stated dividend rate of 6.875% and a liquidation preference of $1,000 per preferred share (equivalent to $25 per depositary share). The offering generated approximately $392.2 million in net proceeds after underwriting discounts and estimated offering expenses.
The company filed a Certificate of Designations amending its charter to establish the Series B rights, and issued the depositary shares pursuant to a Deposit Agreement with Computershare. Holders of the depositary shares are entitled to proportional dividend, voting, redemption and liquidation rights. The Series B includes provisions that restrict the company’s ability to pay dividends on, distribute or repurchase common stock if dividends on the Series B were not declared and either paid or set aside for the immediately preceding dividend period.
Comerica Incorporated submitted a Form 144 reporting a proposed sale of 2,100 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $140,773.50. The filing lists the approximate date of sale as 08/08/2025 and names the NYSE as the exchange, and reports total shares outstanding of 128,525,470.
The notice includes the acquisition history for the shares, showing multiple lots acquired between 03/31/2023 and 06/30/2025 via ESPP purchases and restricted stock vesting (notable vesting amounts include 854 and 524 shares). The provided content does not include the filer’s identifying CIK or filer name in the visible fields.
Comerica Incorporated reports a proposed insider sale of 4,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an approximate sale date of 08/08/2025. The filing lists an aggregate market value of $269,140 and shows 128,525,470 shares outstanding, indicating the sale represents a very small fraction of total equity.
The shares were acquired as restricted stock vesting on 01/26/2023 (1,274 shares) and 02/28/2023 (2,726 shares) and were paid as compensation. The filer reports "Nothing to Report" for securities sold in the past three months and affirms no undisclosed material adverse information.